Understanding Excess Androgen in CAH and FMPP
This is an observational study to better understand the effects of having too much androgen (a male-like hormone) in your body. Researchers are gathering information from people with genetic conditions like Congenital Adrenal Hyperplasia (CAH) and Familial Male-Limited Precocious Puberty (FMPP) to learn more about how excess androgen affects growth, hormones, and even mood. The goal is to create a full picture of these conditions, which can lead to problems like early puberty, short height, infertility, or changes in appearance. This study will help scientists design better treatments in the future. You may be able to join if you have CAH, FMPP, or excess androgen of unknown cause, or if you are a relative of someone in the study. All ages and genders are welcome, except for females with isolated polycystic ovary syndrome.
- Study design
- This is an observational study, meaning researchers will collect information without giving any specific interventions. The study plans to include up to 3000 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary goal of understanding the comprehensive profile of patients is measured as "Ongoing," suggesting continuous data collection rather than a fixed follow-up period after an intervention.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Natural History Study of Patients With Excess Androgen
At a glance
Conditions
NCT00250159
Where you'd take part
This study runs at 2 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
National Institutes of Health Clinical Center
Bethesda, Marylandstudy coordinator listed
Recruiting
Medstar Washington Hospital Center
Washington D.C., District of Columbiano site contact published
Completed
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Deborah P Merke, M.D. · PRINCIPAL_INVESTIGATOR · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- To elucidate a comprehensive phenotypic profile for patients with CAH and FMPPOngoing
Better understanding of CAH and FMPP